151 related articles for article (PubMed ID: 18636193)
1. S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3.
He Z; Gao J; Wang Q; Liu M; Li Y; Li X; Tang H; Zheng J
Oncol Rep; 2008 Aug; 20(2):325-32. PubMed ID: 18636193
[TBL] [Abstract][Full Text] [Related]
2. S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro.
Wang Q; He Z; Gao J; Hu S; Huang M; Liu M; Zheng J; Tang H
Cancer Lett; 2008 Dec; 272(2):277-84. PubMed ID: 18762368
[TBL] [Abstract][Full Text] [Related]
3. Low expression of S100P associated with paclitaxel resistance in ovarian cancer cell line.
Gao JH; He ZJ; Wang Q; Li X; Li YX; Liu M; Zheng JH; Tang H
Chin Med J (Engl); 2008 Aug; 121(16):1563-8. PubMed ID: 18982869
[TBL] [Abstract][Full Text] [Related]
4. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
5. Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP.
Tang H; Liu YJ; Liu M; Li X
Anticancer Drugs; 2007 Jul; 18(6):633-9. PubMed ID: 17762391
[TBL] [Abstract][Full Text] [Related]
6. Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro.
Leong CT; Ong CK; Tay SK; Huynh H
Oncogene; 2007 Feb; 26(6):870-80. PubMed ID: 16862170
[TBL] [Abstract][Full Text] [Related]
7. S100P enhances the chemosensitivity of human gastric cancer cell lines.
Zhao X; Bai Z; Wu P; Zhang Z
Cancer Biomark; 2013; 13(1):1-10. PubMed ID: 23736016
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
Andrews P; Zhao X; Allen J; Li F; Chang M
Cancer Chemother Pharmacol; 2008 Feb; 61(2):203-14. PubMed ID: 17447067
[TBL] [Abstract][Full Text] [Related]
9. [Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
Geng M; Yin YC; Cao YC; Fu ZJ; Wang XY; Tai YH
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):838-41. PubMed ID: 18396642
[TBL] [Abstract][Full Text] [Related]
10. S-phase reduction in T47D human breast cancer epithelial cells induced by an S100P antisense-retroviral construct.
Beissel B; Silva ID; Pesquero JB; Russo J; Schor N; Bellini MH
Oncol Rep; 2007 Mar; 17(3):611-5. PubMed ID: 17273741
[TBL] [Abstract][Full Text] [Related]
11. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.
Whiteman HJ; Weeks ME; Dowen SE; Barry S; Timms JF; Lemoine NR; Crnogorac-Jurcevic T
Cancer Res; 2007 Sep; 67(18):8633-42. PubMed ID: 17875703
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy.
Sato S; Itamochi H; Kigawa J; Oishi T; Shimada M; Sato S; Naniwa J; Uegaki K; Nonaka M; Terakawa N
Cancer Sci; 2009 Mar; 100(3):546-51. PubMed ID: 19154404
[TBL] [Abstract][Full Text] [Related]
13. Expression of S100P protein correlates with and contributes to the tumorigenic capacity of HeLa cervical carcinoma cells.
Gibadulinová A; Baráthová M; Kopácek J; Hulíková A; Pastoreková S; Kettmann R; Pastorek J
Oncol Rep; 2005 Aug; 14(2):575-82. PubMed ID: 16012747
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells.
Zou W; Yang H; Hou X; Zhang W; Chen B; Xin X
Cancer Lett; 2007 Apr; 248(2):211-8. PubMed ID: 16930823
[TBL] [Abstract][Full Text] [Related]
15. Livin gene plays a role in drug resistance of colon cancer cells.
Wang X; Xu J; Ju S; Ni H; Zhu J; Wang H
Clin Biochem; 2010 May; 43(7-8):655-60. PubMed ID: 20171199
[TBL] [Abstract][Full Text] [Related]
16. PRL-3 phosphatase is implicated in ovarian cancer growth.
Polato F; Codegoni A; Fruscio R; Perego P; Mangioni C; Saha S; Bardelli A; Broggini M
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6835-9. PubMed ID: 16203771
[TBL] [Abstract][Full Text] [Related]
17. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
Ho TF; Peng YT; Chuang SM; Lin SC; Feng BL; Lu CH; Yu WJ; Chang JS; Chang CC
Toxicol Appl Pharmacol; 2009 Mar; 235(2):253-60. PubMed ID: 19133282
[TBL] [Abstract][Full Text] [Related]
18. [Effect of survivin shRNA on chemosensitivity of human ovarian cancer cell line OVCAR3 to paclitaxel].
Yan XJ; Liang LZ; Zeng ZY; Shi Z; Fu LW
Ai Zheng; 2006 Apr; 25(4):398-403. PubMed ID: 16613669
[TBL] [Abstract][Full Text] [Related]
19. Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol.
Thomadaki H; Scorilas A
Biol Chem; 2008 Nov; 389(11):1427-34. PubMed ID: 18783338
[TBL] [Abstract][Full Text] [Related]
20. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer.
Yu X; Liu L; Cai B; He Y; Wan X
Cancer Sci; 2008 Mar; 99(3):543-52. PubMed ID: 18201274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
